Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label study of Begrivac influenza vaccine in healthy adults and elderly
2010-018371-18Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Agrippal S1 in influenza (2 arms), sponsored by Novartis. Primary endpoints: Immunogenicity endpoints and Safety endpoints. Started Mar 2010; status: completed.
02
Drugs
Agrippal S1
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-018371-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018371-18.